---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-095883"
form_type: "8-K"
ticker: "LSH"
cik: "0001996192"
company_name: "Lakeside Holding Ltd"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T03:03:50.755278+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lakeside subsidiary to acquire 100% of Hupan Pharmaceutical for RMB4M (US$0.6M)

## Summary
- Lakeside's subsidiary Sichuan Hupan signs deal to acquire 100% of Hupan Pharmaceutical for RMB4.0M (US$0.6M).
- Payment in three installments: 20% prepayment (RMB800K) within 7 days post-signing, 60% after conditions, 20% on completion.
- Sellers Hubei Haoyaoshi (90%) and Hubei Huayao (10%) transfer all equity; no third-party interests.
- Target provides pharmaceutical distribution, supply chain, brand promotion, and healthcare technology support.

## SEC filing metadata
- accession: 0001213900-24-095883
- form_type: 8-K
- ticker: LSH
- cik: 0001996192
- company_name: Lakeside Holding Ltd
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1996192/000121390024095883/0001213900-24-095883-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1996192/000121390024095883/ea0220168-8k_lakeside.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-095883
- JSON: https://secwatch.observer/filing/0001213900-24-095883.json
- Plain text: https://secwatch.observer/filing/0001213900-24-095883.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.